000			01898cam a2200409 i 4500
001			2012018433
005			20240305165658.0
006			m o d
007			cr un ---uuuua
008			120503t20122012ilu ob 001 0 eng d
010			_a 2012018433
020			_a9781614384786
035			_a40481
040			_aUtOrBLW _beng _erda _cUtOrBLW
042			_apcc
043			_an-us---
050	0	0	_aKF3133.B56 _bA86 2012
082	0	0	_a346.7304/86 _223
245	0	0	_aANDA litigation : _bstrategies and tactics for pharmaceutical patent litigators / _cKenneth L. Dorsney, editor-in-chief.
246	3	0	_aAbbreviated New Drug Application litigation
264		1	_aChicago : _bAmerican Bar Association, Section of Intellectual Property Law, _c[2012]
264		4	_c©2012
300			_a1 online resource (xxiii, 809 pages)
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
504			_aIncludes bibliographical references and index.
505	0		_aStatutory and regulatory scheme -- Drug approval process - an overview -- Notice and pre-filing considerations -- Litigation timeline -- Initiating litigation -- Responding to the complaint -- Discovery -- Experts -- Claim construction -- Summary judgment -- Remedies -- Settlement -- Antitrust -- Pretrial preparation -- Trial -- Post-trial -- Appeals to the court of appeals for the federal circuit -- Pharmaceutical regulation and litigation in foreign countries -- Managing an ANDA litigation.
650		0	_aBiotechnology _zUnited States _xPatents.
650		0	_aDrugs _zUnited States _xPatents.
650		0	_aPatent suits _zUnited States.
650		0	_aPharmacy _xLaw and legislation _zUnited States.
653			_aAbbreviated New Drug Application.
700	1		_aDorsney, Kenneth L.
856	4	0	_uhttps://app.vlex.com/#/sources/40481
942			_cRAA
999			_c173265 _d173265